SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CPHD - Cephid
CPHD 52.950.0%Nov 8 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Astarte who wrote (4)3/12/2002 6:55:31 PM
From: Ron   of 8
 
Anyone think CPHD might be a good longer term buy and hold?
BALTIMORE -(Dow Jones)- Cepheid (CPHD) agreed to collaborate with a Northrop Grumman Corp. (NOC) unit and a unit of Smiths Aerospace, London , in order to develop DNA-based, bio-threat detection technology for use on U.S. Postal Service mail-sorting systems.

Cepheid said the U.S. Postal Service recently announced an evaluation of polymerase chain reaction technology for possible deployment later this year, but no contract has been awarded, at this time.

In a press release Monday, Cepheid said the proposed system will use PCR technology to analyze air samples from mail-sorting systems for trace levels of DNA from anthrax spores and other biological agents.

The company is collaborating with Northrop Grumman (NYSE: NOC - news) 's automation and information systems division, and with Smiths Aerospace's Environmental Technologies Group Inc. unit.

Cepheid, Sunnyvale , Calif. , makes and sells systems for rapid, on-site detection of DNA.

Company Web sites: cepheid.com; northrop-grumman.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext